Abstract:BACKGROUND: Computed tomography-derived fractional flow reserve (CT-FFR) using on-site machine learning enables identification of both the presence of coronary artery disease and vessel-specific ischemia. However, it is unclear whether on-site CT-FFR improves clinical or economic outcomes when compared with the standard of care in patients with stable coronary artery disease. METHODS: In total, 1216 patients with stable coronary artery disease and an intermediate stenosis of 30% to 90% on coronary computed tomographic angiography were randomized to an on-site CT-FFR care pathway using machine learning or to standard care in 6 Chinese medical centers. The primary end point was the proportion of patients undergoing invasive coronary angiography without obstructive coronary artery disease or with obstructive disease who did not undergo intervention within 90 days. Secondary end points included major adverse cardiovascular events, quality of life, symptoms of angina, and medical expenditure at 1 year. RESULTS: Baseline characteristics were similar in both groups, with 72.4% (881/1216) having either typical or atypical anginal symptoms. A total of 421 of 608 patients (69.2%) in the CT-FFR care group and 483 of 608 patients (79.4%) in the standard care group underwent invasive coronary angiography. Compared with standard care, the proportion of patients undergoing invasive coronary angiography without obstructive coronary artery disease or with obstructive disease not undergoing intervention was significantly reduced in the CT-FFR care group (28.3% [119/421] versus 46.2% [223/483]; P < 0.001). Overall, more patients underwent revascularization in the CT-FFR care group than in the standard care group (49.7% [302/608] versus 42.8% [260/608]; P=0.02), but major adverse cardiovascular events at 1 year did not differ (hazard ratio, 0.88 [95% CI, 0.59-1.30]). Quality of life and symptoms improved similarly during follow-up in both groups, and there was a trend towards lower costs in the CT-FFR care group (difference, -Upsilon 4233 [95% CI, -Upsilon 8165 to Upsilon 973]; P=0.07). CONCLUSIONS: On-site CT-FFR using machine learning reduced the proportion of patients with stable coronary artery disease undergoing invasive coronary angiography without obstructive disease or requiring intervention within 90 days, but increased revascularization overall without improving symptoms or quality of life, or reducing major adverse cardiovascular events.

Treatment of Coronary Slow Flow Phenomenon with Trimetazidine and Atorvastatin

Clinical Study on Treatment of Coronary Slow Flow Phenomenon with Tongxinluo Capsules

Effect of atorvastatin on patients with coronary slow flow

Effects of Trimetazidine on Ventricular Remodeling in Coronary Artery Disease Patients with Left Ventricular Hypertrophy: the Rationale and Design of a Randomized Controlled Trial.

Effect of trimetazidine for PCI were related myocardial ischemia-reperfusion injury and prognosis

The Effect of Verapamil and Nitroglycerin on the Coronary Slow Flow Phenomenon

Upright Biplanar Slot Scanning in Pediatric Orthopedics: Applications, Advantages, and Artifacts.

[Atorvastatin use and coronary flow reserve in patients with coronary slow flow]

On-Site Computed Tomography-Derived Fractional Flow Reserve to Guide Management of Patients With Stable Coronary Artery Disease: The TARGET Randomized Trial

Effect of nifedipine controlled released tablet and atorvastatin on carotid intimamedia thickness and vascular endothelial function in patients with hypertension

Efficacy and Safety of Serial Atorvastatin Load in Chinese Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the ISCAP (intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) Randomized Controlled Trial

Clinical Effectiveness of Automated Coronary CT-derived Fractional Flow Reserve: A Chinese Randomized Controlled Trial

[Clinical Outcomes of Trimetazidine in Patients with Acute ST Segment Elevation Myocardial Infarction Without ST Segment Resolution after Primary Percutaneous Coronary Intervention].

Impact of Trimetazidine on Angina Frequency and Exercise Tolerance in Patients Undergoing Percutaneous Coronary Intervention

ANTI-ISCHEMIC EFFECTIVENESS OF TRIMETAZIDINE 80 MG ONCE DAILY IN PATIENTS WITH STABLE ANGINA AND A HISTORY OF MYOCARDIAL INFARCTION. RESULTS OF THE METHOD STUDY

The effect of on-site CT-derived fractional flow reserve on the management of decision making for patients with stable chest pain (TARGET trial): objective, rationale, and design

Quantitative analysis of myocardial perfusion in patients with coronary slow flow by real-time myocardial contrast echocardiography

Comparison of two pig intestinal brush border peptidases with the corresponding renal enzymes.

Chronologic Evolution and Prognostic Implications of Impaired Coronary Flow after Chronic Total Occlusion Angioplasty.

Effect of coronary injection of nitroglycerin and verapamil on slow blood flow and no reflow during PCI of coronary heart disease

Incremental Value of Coronary Flow Reserve Assessed by CZT-SPECT in the Diagnosis of Coronary Ar-Tery Disease